A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

This study is currently recruiting participants.
Verified November 2013 by Emory University
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Taofeek K. Owonikoko, Emory University
ClinicalTrials.gov Identifier:
NCT01470209
First received: October 25, 2011
Last updated: November 18, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)